Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 4:58 pm Sale | 13G | AKEBIA THERAPEUTICS INC AKBA | VANGUARD GROUP INC | 7,607,472 4.04% | -3,631,398 (-32.31%) | View |
| 2024-02-09 4:00 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | Satter Muneer A | 16,205,119 8.6% | 1,115,000 (+7.39%) | View |
| 2023-02-10 1:08 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | Satter Muneer A | 15,090,119 8.2% | 1,225,789 (+8.84%) | View |
| 2023-02-09 10:54 am Sale | 13G | AKEBIA THERAPEUTICS INC AKBA | VANGUARD GROUP INC | 11,238,870 6.11% | -7,120,550 (-38.78%) | View |
| 2023-01-20 08:55 am Sale | 13G | AKEBIA THERAPEUTICS INC AKBA | STATE STREET CORP STT | 571,936 0.31% | -11,171,525 (-95.13%) | View |
| 2022-12-19 4:10 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | Satter Muneer A | 13,864,330 7.5% | 10,797,287 (+352.04%) | View |
| 2022-07-08 4:56 pm Sale | 13G | AKEBIA THERAPEUTICS INC AKBA | BlackRock Inc. BLK | 4,340,026 2.4% | -9,784,189 (-69.27%) | View |
| 2022-06-09 2:15 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | VANGUARD GROUP INC | 18,359,420 10% | 5,123,751 (+38.71%) | View |
| 2022-02-10 1:23 pm Sale | 13G | AKEBIA THERAPEUTICS INC AKBA | STATE STREET CORP STT | 11,743,461 6.71% | -2,263,176 (-16.16%) | View |
| 2022-02-09 3:16 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | VANGUARD GROUP INC | 13,235,669 7.56% | 4,800,910 (+56.92%) | View |
| 2022-02-07 4:41 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | BlackRock Inc. BLK | 14,124,215 8.1% | 2,726,667 (+23.92%) | View |
| 2021-08-10 07:57 am Sale | 13G | AKEBIA THERAPEUTICS INC AKBA | WELLINGTON MANAGEMENT GROUP LLP | 711 0% | -12,589,752 (-99.99%) | View |
| 2021-07-12 10:45 am Sale | 13G | AKEBIA THERAPEUTICS INC AKBA | STATE STREET CORP STT | 14,006,637 8.75% | -8,469,897 (-37.68%) | View |
| 2021-02-12 06:42 am Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | Nantahala Capital Management LLC | 7,040,487 4.9% | 303,367 (+4.50%) | View |
| 2021-02-11 12:43 pm Sale | 13G | AKEBIA THERAPEUTICS INC AKBA | STATE STREET CORP STT | 22,476,534 15.55% | -340,636 (-1.49%) | View |
| 2021-02-10 10:30 am Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | VANGUARD GROUP INC | 8,434,759 5.84% | 8,434,759 (New Position) | View |
| 2021-02-10 10:26 am Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | STATE STREET CORP STT | 22,817,170 15.79% | 7,476,699 (+48.74%) | View |
| 2021-02-03 1:33 pm Sale | 13G | AKEBIA THERAPEUTICS INC AKBA | WELLINGTON MANAGEMENT GROUP LLP | 12,590,463 8.71% | -5,107,650 (-28.86%) | View |
| 2021-01-28 5:56 pm Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | BlackRock Inc. BLK | 11,397,548 7.9% | 1,136,401 (+11.07%) | View |
| 2020-11-10 09:02 am Purchase | 13G | AKEBIA THERAPEUTICS INC AKBA | WELLINGTON MANAGEMENT GROUP LLP | 17,698,113 12.35% | 17,698,113 (New Position) | View |